Dr Georg Casari
Chief Executive Officer (CEO) and co-founder
Dr Casari has worked at several high-ranking institutes including the European Molecular Biology Laboratory (EMBL) in Germany and the European Bioinformatics Institute (EBI) in the UK. For the last 15 years, he has worked for biotech start-up companies and was a founder of LION Bioscience, which had the largest biotech IPO in Germany's history.
Dr Wolfgang Fischl
Head of Research
Dr Fischl has been trained as a biologist and virologist at University in Vienna and University of Heidelberg. He has worked on the elucidation of the infection cycle of Tick-borne encephalitis virus (TBEV) and dengue virus. Since 2012 he has lead the internal antiviral programs at Haplogen and progressed internal projects from early stage of a putative target to solid validated programs with chemical lead molecules ready for preclinical development.